On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Taiwan Centers for Disease Control

InstitutionResearch output, impact & collaborations

Taiwan Centers for Disease Control is a institution indexed in ScholarIQ from OpenAlex.

What is known about Taiwan Centers for Disease Control?

ScholarIQrecord summary

Taiwan Centers for Disease Control is a research organisation in Taipei, TW. OpenAlex records 9,775 works and 413,491 citations for it. 4,731 researchers list it as their most recent affiliation.

How many works does Taiwan Centers for Disease Control have?

ScholarIQindexed works

Taiwan Centers for Disease Control has 9,775 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Taiwan Centers for Disease Control have?

ScholarIQcitation count

Taiwan Centers for Disease Control has 413,491 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Taiwan Centers for Disease Control?

ScholarIQresearcher count

Taiwan Centers for Disease Control has 4,731 researchers in the ScholarIQ index.

What is the average h-index at Taiwan Centers for Disease Control?

ScholarIQavg h-index

Taiwan Centers for Disease Control has an average h-index of 38 in OpenAlex.

What is the ROR of Taiwan Centers for Disease Control?

ScholarIQror

The ROR for Taiwan Centers for Disease Control is on the source record.

What is the OpenAlex record for Taiwan Centers for Disease Control?

ScholarIQopenalex

The OpenAlex for Taiwan Centers for Disease Control is on the source record.

Who are the most-cited researchers behind Taiwan Centers for Disease Control?

ScholarIQtop researchers by citations
1
Yong Zhang · Viral Infections and Immunology Research
504 works16,143 citations
2
Ming Zeng · Lung Cancer Diagnosis and Treatment
153 works3,207 citations

What are the most-cited papers on Taiwan Centers for Disease Control?

ScholarIQmost cited works
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
Jing Huang, Jianming Xu, Yun Chen, Wu Zhuang, Yiping Zhang, Zhendong Chen, Jia Chen, Helong Zhang, Zuoxing Niu, Qingxia Fan, Lizhu Lin, Kangsheng Gu, Ying Liu, Yi Ba, Zhanhui Miao, Xiaodong Jiang, Ming Zeng, Jianhua Chen, Zhichao Fu, Lu Gan, Jun Wang, Xianbao Zhan, Tianshu Liu, Zhiping Li, Lin Shen, Yongqian Shu, Tao Zhang, Qing Yang, Jianjun Zou, Suxia Luo, Feng Peng, Gang Wu, Nong Xu, Lin Zhao, Dong Ma, Shukui Qin, Wei Ren, Enxiao Li, Hongda Lu, Yueyin Pan, Jianping Xiong, Ying Yuan, Yuxian Bai, Lei Chen, Yi Hu, Li Zhang, Yong Gao
The Lancet Oncology. 2020591 Citations
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial
Ming Zeng, Xuhu Mao, Jingxin Li, Wende Tong, Bin Wang, Yiju Zhang, Gang Guo, Zhijing Zhao, Liang Li, Delin Wu, Dongshui Lu, Zhongming Tan, Haoyu Liang, Chao Wu, Da-Han Li, Ping Luo, Hao Zeng, Weijun Zhang, Jinyu Zhang, Botao Guo, Fengcai Zhu, Quanming Zou
The Lancet. 2015299 Citations
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
Xiaoshan Wang, Yifeng Bai, Vivek Verma, Ruilian Yu, Wei Tian, Rui Ao, Ying Deng, Xue-Qiang Zhu, Hao Liu, Haixia Pan, Lan Yang, Hansong Bai, Xing Luo, Yan Guo, Mingxiu Zhou, Yuemei Sun, Zi-Can Zhang, Simin Li, Xue Cheng, Bangxian Tan, Liang-Fu Han, Yingyi Liu, Kai Zhang, Fanxin Zeng, Lin Jia, Xinbao Hao, You‐Yu Wang, Gang Feng, Ke Xie, You Lü, Ming Zeng
JNCI Journal of the National Cancer Institute. 2022266 CitationsOPEN ACCESS
Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in <i>LKB1</i> -Mutant Lung Cancer
Yan Liu, Kevin Marks, Glenn S. Cowley, Julián Carretero, Qingsong Liu, Thomas J.F. Nieland, Chunxiao Xu, Travis J. Cohoon, Peng Gao, Yong Zhang, Zhao Chen, Abigail B. Altabef, Jeremy H. Tchaicha, Xiaoxu Wang, Sung Choe, Edward M. Driggers, Jianming Zhang, Sean T. Bailey, Norman E. Sharpless, D. Neil Hayes, Nirali M. Patel, Pasi A. Jänne, Nabeel Bardeesy, Jeffrey A. Engelman, Brendan D. Manning, Reuben J. Shaw, John M. Asara, Ralph Scully, Alec C. Kimmelman, Lauren A. Byers, Don L. Gibbons, Ignacio I. Wistuba, John V. Heymach, David J. Kwiatkowski, William Y. Kim, Andrew L. Kung, Nathanael S. Gray, David E. Root, Lewis C. Cantley, Kwok‐Kin Wong
Cancer Discovery. 2013152 CitationsOPEN ACCESS
Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer
Yongling Ji, Xianghui Du, Weiguo Zhu, Yanguang Yang, Jun Ma, Li Zhang, Jiancheng Li, Hua Tao, Jianhong Xia, Haihua Yang, Jin Huang, Yong Bao, Dexi Du, Degan Liu, Xiusheng Wang, Chaoming Li, Xinmei Yang, Ming Zeng, Zhigang Liu, Wen Zheng, Juan Pu, Jun Chen, Wangyuan Hu, Peijing Li, Jin Wang, Yujin Xu, Xiao Zheng, Jianxiang Chen, Wanwei Wang, Guangzhou Tao, Jing Cai, Jizhong Zhao, Jun Zhu, Ming Jiang, Yan Yan, Guoping Xu, Shanshan Bu, Binbin Song, Ke Xie, Shan Huang, Yuanda Zheng, Liming Sheng, Xiaojing Lai, Ying Chen, Lei Cheng, Xiao Hu, Wenhao Ji, Min Fang, Yue Kong, Xiaofu Yu, Huizhang Li, Runhua Li, Lei Shi, Wei Shen, Chaonan Zhu, Junwei Lv, Rong Huang, Han He, Ming Chen
JAMA Oncology. 2021111 CitationsOPEN ACCESS

How much of the research on Taiwan Centers for Disease Control is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
25%
Green
0%
Hybrid
25%
Bronze
17%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial